AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis Siddharth Singh et al. Background…
Use of biologics for the management of Crohn’s disease: IG-IBD clinical guidelines based on the GRADE methodology FABIO MACALUSO ED…
GUT MICROBIAL METABOLISM OF 5-ASA IS PROSPECTIVELY ASSOCIATED WITH TREATMENT FAILURE IN PATIENTS WITH IBD Raaj Mehta et al. Abstract…
Dietary interventions for the treatment of inflammatory bowel diseases: an updated systematic review and meta-analysis Berkeley N. Limketkai et al.…
Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn- or postbiotics?…
Understanding the development and function of the gut microbiota in health and inflammation Deepak Selvakuma et al. Abstract The…
Self-expandable metal stents versus endoscopic balloon dilation for the treatment of strictures in Crohn’s disease (ProtDilat study): an open-label, multicentre,…
Systematic review with meta-analysis: the effectiveness of either ustekinumab or vedolizumab in patients with Crohn’s disease refractory to anti-tumour necrosis…
Systemic Inflammation in Preclinical Ulcerative Colitis Daniel Bergemalm et al. BACKGROUND & AIMS: Preclinical ulcerative colitis is poorly defined. We…
AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review Sanjay K.…
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease Daniel C. Baumgart et al. Crohn’s disease and ulcerative colitis, together…
The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis Jean-Frédéric LeBlanc et al. Abstract The gut microbiome has been…
Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients Eelco C. Brand et al.…
The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable Anita Afzali et al. Abstract In the USA, an…
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations Stephan Miehlke et al.…
The Global Incidence of Faecal Microbiota Transplantation-related Adverse Events From 2000 to 2020 Cicilia Marcella et al. Abstract Background: Faecal microbiota…
The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis…
The intestinal barrier, an arbitrator turned provocateur in IBD Mehandru S, and Colombel JF Key studies published in 2020 demonstrate…
The Microbiota-Gut-Brain Axis: From Motility to Mood Kara G. Margolis et al. Abstract The gut-brain axis plays an important role…
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease. Angela Ancona et al. Introduction Gut microbiota (GM) has…
Infezione da Clostridium difficile e malattie infiammatorie croniche intestinali LUCIO CAPURSO1, MAURIZIO KOCH2 1Primario Emerito Gastroenterologia, Ospedale San Filippo Neri, Roma; 2Senior Director,…
Combination Therapy with Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy-a Post-hoc analysis.Colombel JF, Adedokun OJ, Gasink C, Gao…
Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.Miehlke S, Aust D, Mihaly E,…
Methotrexate is not superior to placebo in maintaining steroid-free response or remission in ulcerative colitis.Herfarth H, Barnes EL, Valentine JF,…
Il nostro sito Web utilizza i cookies e quindi raccoglie informazioni sulla tua visita per migliorare la consultazione del sito (analizzando le tue scelte), per mostrarti i contenuti dei social media e annunci pertinenti.Consulta la nostra pagina cookies per ulteriori dettagli o accetta facendo clic sul pulsante "Accetta".
Di seguito puoi scegliere quale tipo di cookies consentire su questo sito.Fare clic sul pulsante "Salva impostazioni cookies" per applicare la scelta.
FunzionaliIl nostro sito web utilizza cookie funzionali. Questi cookie sono necessari per far funzionare il nostro sito web.
AnaliticiIl nostro sito Web utilizza cookie analitici per consentire di analizzare il nostro sito Web e ottimizzarlo ai fini a.o. l'usabilità.
Social mediaIl nostro sito web inserisce cookie di social media per mostrarti contenuti di terze parti come YouTube e FaceBook. Questi cookie possono tracciare i tuoi dati personali.
PubblicitariIl nostro sito web inserisce cookie pubblicitari per mostrarti pubblicità di terze parti in base ai tuoi interessi. Questi cookie possono tracciare i tuoi dati personali.
AltriIl nostro sito web inserisce cookie di terze parti da altri servizi di terze parti che non sono analitici, social media o pubblicitari.
Questo contenuto è bloccato. Accetta i cookies nella categoria '%CC%' per visualizzare questo contenuto.